An article from '02:
Tentative evidence supports a beneficial role as add-on therapy in colorectal cancer -- Deva S, Jameson M (15 August 2012). "Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer". The Cochrane Database of Systematic Reviews. 8 (8): CD007814